Cancer incidence and the risk for multiple primary cancers in neurofibromatosis type 1

Clicks: 5
ID: 323618
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #31 of 332 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 332 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Neurofibromatosis 1 (NF1) is a cancer predisposition syndrome caused by pathogenic variants of the NF1 gene. Here, we analyze the incidence and risk of cancer and especially the risk of multiple primary cancers in individuals with NF1. METHODS: The previously established Finnish NF1 cohort was extended to include 1,811 individuals with verified NF1 and followed up using the nationwide Finnish Cancer Registry for 30,612 person-years over 1987-2020. Standardized incidence ratios (SIRs) were used to analyze cancer incidence. RESULTS: A total of 296 first primary cancers occurred in individuals with NF1 during the follow-up, yielding an SIR of 4.92 (95% CI 4.38-5.52). The SIR was 4.30 (95% CI 3.27-5.54) for second primary cancers with 59 cancers observed. Therefore, the history of first primary cancer did not, in general, indicate altered risk for second primary cancer among individuals with NF1 (P=0.377). Overall, NF1 was associated with a steadily increasing cumulative risk for cancer throughout the lifetime. Women with NF1 had a 20.9% (95% CI 15.9-27.4%) lifetime risk for breast cancer with significantly increased incidence at ages <50 and ≥50 years (SIRs 4.90, 95% CI 2.99-7.56 and 2.67, 95% CI 1.76-3.89, respectively). CONCLUSION: The history of a prior cancer does not predict the overall future risk for cancer in NF1. Nevertheless, the estimates are consistent with some subpopulations having an increased risk for multiple cancers. Regarding breast cancer predisposition, the results confirm NF1 as a moderate-risk gene linked to increased incidence across all ages, i.e., not only in young women.
Reference Key
openalex_W7172449078 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Roope A. Kallionpää, Sirkku Peltonen, Elina Uusitalo, Jussi Leppävirta, Mari Hellen, Niina Loponen, Matti Rantanen, Karri Seppä, Tommi Frang, Lotta Vihervaara, Heli Ylä‐Outinen, Janne Pitkäniemi, Minna Pöyhönen, Juha Peltonen
Journal JNCI Journal of the National Cancer Institute
Year 2026
DOI
10.1093/jnci/djag269
URL
https://doi.org/10.1093/jnci/djag269
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.